Forus is a fast-growing, AI-first health technology company dedicated to revolutionizing the way new therapies are brought to market. By leveraging advanced artificial intelligence, Forus streamlines complex biopharma processes, helping to bridge the gap between scientific discovery and patient care.
Backed by industry-leading venture capital firms including Thrive Capital, General Catalyst, and Accel, Forus is uniquely positioned to scale its impact. The company fosters a high-performance culture characterized by intellectual rigor, direct communication, and a shared commitment to improving global health outcomes through technology.